N-(4-Methoxybenzoyl)-L-valyl]-N-[(1S)-3,3,3-Tr ifluor-1-isopropyl2-oxopropyl]-L-prolinamide manufacturers
- ZD-0892
-
- $71.00
-
2026-08-30
- CAS:171964-73-1
- Purity: 99.53%
- Supply Ability: 10g
- ZD-0892
-
- $71.00
-
2026-08-19
- CAS:171964-73-1
- Purity: 99.53%
- Supply Ability: 10g
|
| | N-(4-Methoxybenzoyl)-L-valyl]-N-[(1S)-3,3,3-Tr ifluor-1-isopropyl2-oxopropyl]-L-prolinamide Basic information |
| Product Name: | N-(4-Methoxybenzoyl)-L-valyl]-N-[(1S)-3,3,3-Tr ifluor-1-isopropyl2-oxopropyl]-L-prolinamide | | Synonyms: | L-Prolinamide, N-(4-methoxybenzoyl)-L-valyl-N-[(1S)-3,3,3-trifluoro-1-(1-methylethyl)-2-oxopropyl]-;ZD0892,ZD 0892;(S)-1-((4-Methoxybenzoyl)-L-valyl)-N-((S)-1,1,1-trifluoro-4-methyl-2-oxopentan-3-yl)pyrrolidine-2-carboxamide;(S)-1-[(S)-2-(4-methoxybenzamido)-3-methylbutyryl]-N-[(S)-2-methyl-1-(trifluoroacetyl)propyl]pyrrolidine-2-carboxamide;ZD-0892;N-(4-Methoxybenzoyl)-L-valyl]-N-[(1S)-3,3,3-Tr ifluor-1-isopropyl2-oxopropyl]-L-prolinamide | | CAS: | 171964-73-1 | | MF: | C24H32F3N3O5 | | MW: | 499.52 | | EINECS: | | | Product Categories: | | | Mol File: | 171964-73-1.mol | ![N-(4-Methoxybenzoyl)-L-valyl]-N-[(1S)-3,3,3-Tr ifluor-1-isopropyl2-oxopropyl]-L-prolinamide Structure](CAS/20200515/GIF/171964-73-1.gif) |
| | N-(4-Methoxybenzoyl)-L-valyl]-N-[(1S)-3,3,3-Tr ifluor-1-isopropyl2-oxopropyl]-L-prolinamide Chemical Properties |
| Boiling point | 677.9±55.0 °C(Predicted) | | density | 1.227±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 12.20±0.20(Predicted) | | form | Solid | | color | White to off-white |
| | N-(4-Methoxybenzoyl)-L-valyl]-N-[(1S)-3,3,3-Tr ifluor-1-isopropyl2-oxopropyl]-L-prolinamide Usage And Synthesis |
| Uses | ZD-0892 is a selective and potent inhibitor of a neutrophil elastase with Kis of 6.7 and 200 nM for human neutrophil elastase and porcine pancreatic elastase, respectively. | | in vivo | ZD0892 administration to DBA/2 mice infected with the EMC virus results in reduced myocardial elastolytic activity and coronary microvascular perfusion injury. ZD0892 decreases the pathologic severity of the myocardial lesions associated with murine viral myocarditis[1]. ZD-0892 can reverse advanced pulmonary vascular disease produced in rats[2]. | | References | [1] Lee JK, et al. A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis. Nat Med. 1998 Dec;4(12):1383-91. DOI:10.1038/3973 [2] Cowan KN, et al. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med. 2000 Jun;6(6):698-702. DOI:10.1038/76282 |
| | N-(4-Methoxybenzoyl)-L-valyl]-N-[(1S)-3,3,3-Tr ifluor-1-isopropyl2-oxopropyl]-L-prolinamide Preparation Products And Raw materials |
|